Heterogeneous risk profiles among B3 breast lesions of uncertain malignant potential

P. Orsaria, A. Grasso, Rita Carino, E. Caredda, M. Sammarra, C. Altomare, C. Rabitti, G. Gullotta, G. Perrone, F. Pantano, O. Buonomo, V. Altomare
{"title":"Heterogeneous risk profiles among B3 breast lesions of uncertain malignant potential","authors":"P. Orsaria, A. Grasso, Rita Carino, E. Caredda, M. Sammarra, C. Altomare, C. Rabitti, G. Gullotta, G. Perrone, F. Pantano, O. Buonomo, V. Altomare","doi":"10.1177/0300891619868301","DOIUrl":null,"url":null,"abstract":"Background: Most cases of breast lesions of uncertain malignant potential (B3) undergo surgical intervention. We aimed to analyze the outcome of B3 lesion subtypes in a large series of screen-detected cases. Methods: We screened 2,986 core needle biopsies to classify B3 lesions. Positive predictive values (PPVs) for malignancy were calculated for a comprehensive risk characterization according to clinicopathologic and morphologic variables. Results: B3 lesions comprised 35% atypical ductal hyperplasia (PPV = 20%), 16.7% flat epithelial atypia (PPV = 12%), 22.7% lobular neoplasia (PPV = 16.2%), 9% papillary lesion (PPV = 18.5%), 8.6% phyllodes tumor (PPV = 3.8%), and 8% radial scars (PPV = 4.1%) based on histopathologic diagnosis. Upgrade rates were 15.9% for calcifications, 13.7% for mass lesions, and 16.7% for architectural deformities, with 8.3% of malignant lesions classified as ductal carcinoma in situ and 6.7% as invasive cancers (PPV = 15%). Conclusion: B3 lesions entail a heterogeneous risk of malignancy, and careful radiologic–pathologic correlation is required for optimal treatment.","PeriodicalId":23450,"journal":{"name":"Tumori Journal","volume":"8 1","pages":"115 - 125"},"PeriodicalIF":0.0000,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"15","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tumori Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/0300891619868301","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 15

Abstract

Background: Most cases of breast lesions of uncertain malignant potential (B3) undergo surgical intervention. We aimed to analyze the outcome of B3 lesion subtypes in a large series of screen-detected cases. Methods: We screened 2,986 core needle biopsies to classify B3 lesions. Positive predictive values (PPVs) for malignancy were calculated for a comprehensive risk characterization according to clinicopathologic and morphologic variables. Results: B3 lesions comprised 35% atypical ductal hyperplasia (PPV = 20%), 16.7% flat epithelial atypia (PPV = 12%), 22.7% lobular neoplasia (PPV = 16.2%), 9% papillary lesion (PPV = 18.5%), 8.6% phyllodes tumor (PPV = 3.8%), and 8% radial scars (PPV = 4.1%) based on histopathologic diagnosis. Upgrade rates were 15.9% for calcifications, 13.7% for mass lesions, and 16.7% for architectural deformities, with 8.3% of malignant lesions classified as ductal carcinoma in situ and 6.7% as invasive cancers (PPV = 15%). Conclusion: B3 lesions entail a heterogeneous risk of malignancy, and careful radiologic–pathologic correlation is required for optimal treatment.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
不确定恶性潜能的B3乳腺病变的异质性风险概况
背景:大多数乳腺恶性潜能不确定的病变(B3)接受手术治疗。我们的目的是分析大量筛查检测病例中B3病变亚型的结果。方法:筛选2986例核心穿刺活检,对B3病变进行分类。根据临床病理和形态学变量计算恶性肿瘤的阳性预测值(PPVs),以进行全面的风险表征。结果:B3病变包括35%的不典型导管增生(PPV = 20%), 16.7%的扁平上皮异型增生(PPV = 12%), 22.7%的小叶瘤变(PPV = 16.2%), 9%的乳头状病变(PPV = 18.5%), 8.6%的叶状瘤(PPV = 3.8%), 8%的放射状疤痕(PPV = 4.1%)。钙化升级率为15.9%,肿块升级率为13.7%,建筑畸形升级率为16.7%,其中8.3%的恶性病变为导管原位癌,6.7%为浸润性癌(PPV = 15%)。结论:B3型病变具有异质性的恶性风险,需要仔细的影像学和病理学联系才能获得最佳治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trials Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs The digital revolution in pathology: Towards a smarter approach to research and treatment The power of art and the powers of adolescents with cancer: Age-specific projects at Italian pediatric oncology centers bgicc 2024 abstracts
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1